MSCs transfusion effectively suppressed renal fibrosis in experimental models by inhibiting both the pro-inflammatory and pro-fibrotic signaling pathways, including TGF-β1/Smad3, TLR4/NK-κB, and ERK [147,148,149]. The gene discussed is TGFB1; the disease is renal fibrosis.